BioVex News
Most Popular BioVex Story
BioVex - Top 20 Biotech VC Deals of 2009
Company: BioVex GroupBased: Woburn, MAAmount: $70 million Investors: Morningside Venture, Ventech, MVM Life Science Partners, Sectoral Asset Management and Ysios Capital Partners Scoop: Following... Read more...
Latest Headlines
- February 24, 2010
- November 10, 2009
- November 2, 2009
- October 20, 2009
- June 29, 2009
- June 29, 2009
- April 6, 2009
- March 30, 2009
- May 16, 2008
- November 16, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
